announcements & circulars-j9九游会老哥俱乐部
english
j9九游会老哥俱乐部
中文繁体
company
overview
board of directors
scientific advisory board
partnering
core competence
technology
bispecific
mix-mab
biologics manufacturing
publications
pipeline
overview
envafolimab(kn035)
kn046
kn026
kn026 kn046
kn019
investors
information disclosure
corporate governance
stock information
ir contacts
email subscription
news
press release
media report
career
corporate culture
job opportunities
contact us
company
overview
board of directors
scientific advisory board
partnering
core competence
technology
bispecific
mix-mab
biologics manufacturing
publications
pipeline
overview
envafolimab(kn035)
kn046
kn026
kn026 kn046
kn019
investors
information disclosure
corporate governance
stock information
ir contacts
email subscription
news
press release
media report
career
corporate culture
job opportunities
contact us
english
j9九游会老哥俱乐部
中文繁体
investors
information disclosure
listing documents
financial reports
announcements & circulars
company presentation
corporate governance
stock information
ir contacts
email subscription
announcements & circulars
the announcement begins in december 2019
voluntary announcement - kn046 was granted orphan drug designation by the u.s. fda
2020-09-03
interim results announcement for the six months ended june 30, 2020
2020-08-28
date of board meeting
2020-08-18
monthly return of equity issuer on movements in securities for the month ended 31 july 2020
2020-08-06
change of joint company secretary and process agent and waiver from strict compliance with rules 3.28 and 8.17 of the listing rules
2020-07-20
monthly return of equity issuer on movements in securities for the month ended 30 june 2020
2020-07-03
inside information announcement - completion of placing of existing shares by controlling shareholder
2020-06-16
inside information announcement - placing of existing shares by controlling shareholder
2020-06-12
voluntary announcement - co-development of antibody for coronavirus treatment with institut pasteur of shanghai
2020-06-10
voluntary announcement - strategic collaboration with sanofi on kn026 in her2 breast cancer
2020-06-09
4
5
6
7
8
9
10
prev
7/11
next
网站地图